The University Clinical Centre in Gdańsk is the main teaching hospital at the Medical University of Gdańsk. It is a multi-speciality hospital, the largest in the north of Poland and one of the largest in the country.

During the past decade, University Clinical Centre in Gdansk conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Clinical Centre in Gdansk" #1 sponsor was "Ardigen" with 2 trials, followed by "Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Medical University of Gdansk" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Clinical Centre in Gdansk" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator, "First Affiliated Hospital of Zhengzhou University, China" with 1 trials as a collaborator, "Małopolskie Centre of Entrepreneurship" with 1 trials as a collaborator, "Medical Research Agency, Poland" with 1 trials as a collaborator and "Medical University of Bialystok" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "University Clinical Centre in Gdansk" are "Non Small Cell Lung Cancer" (3 trials), "Immunotherapy" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Aortic Valve Stenosis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "University Clinical Centre in Gdansk" in a lesser frequency.

Most popular intervention types in "University Clinical Centre in Gdansk" are "Drug" (7 trials), "Biological" (3 trials), "Device" (3 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "A arm (CLAG-M)" (1 trials), "A arm (DA-90)" (1 trials), "Additional intraoperative analgesia" (1 trials), "Additional postoperative analgesia" (1 trials) and "Alimta Injectable Product" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Clinical Centre in Gdansk" are 13 trials for "All" genders.

Currently, there are NaN active trials in "University Clinical Centre in Gdansk". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University Clinical Centre in Gdansk, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Clinical Centre in Gdansk, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".